Literature DB >> 24528907

Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial.

Lauren Okon1, Misha Rosenbach1, Michael Krathen1, Mathew Rose1, Kathleen Propert2, Joyce Okawa1, Victoria Werth3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24528907      PMCID： PMC4333148          DOI： 10.1016/j.jaad.2013.11.007

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: histologic and circulating leukocyte profile and potential risk of a systemic lupus flare.

Authors:  Inbal Braunstein; Noah G Goodman; Misha Rosenbach; Joyce Okawa; Asha Shah; Michael Krathen; Carrie L Kovarik; Eline Luning Prak; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2011-08-06       Impact factor: 11.527

2.  Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus.

Authors:  Tamara Salam Housman; Joseph L Jorizzo; Martha A McCarty; Sarah E Grummer; Alan B Fleischer; Paul G Sutej
Journal:  Arch Dermatol       Date:  2003-01

3.  Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients.

Authors:  Siamak Moghadam-Kia; Katherine Chilek; Elizabeth Gaines; Melissa Costner; Mathew E Rose; Joyce Okawa; Victoria P Werth
Journal:  Arch Dermatol       Date:  2009-03

4.  Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients.

Authors:  Sylvie Bastuji-Garin; Sophie Ochonisky; Pierre Bouche; Romain K Gherardi; Corinne Duguet; Zaya Djerradine; Florence Poli; Jean Revuz
Journal:  J Invest Dermatol       Date:  2002-11       Impact factor: 8.551

5.  Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus.

Authors:  Josefina Cortés-Hernández; Gabriela Ávila; Miquel Vilardell-Tarrés; Josep Ordi-Ros
Journal:  Arthritis Res Ther       Date:  2012-12-07       Impact factor: 5.156
  5 in total
  15 in total

Review 1.  Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.

Authors:  Joshua Chang; Victoria P Werth
Journal:  Expert Rev Clin Immunol       Date:  2016-06-01       Impact factor: 4.473

Review 2.  Drugs for discoid lupus erythematosus.

Authors:  Sue Jessop; David A Whitelaw; Matthew J Grainge; Prativa Jayasekera
Journal:  Cochrane Database Syst Rev       Date:  2017-05-05

Review 3.  [Lupus erythematosus].

Authors:  C Günther; S Beissert
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

4.  Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus.

Authors:  E Y Wu; L E Schanberg; E C Wershba; C E Rabinovich
Journal:  Lupus       Date:  2016-11-12       Impact factor: 2.911

Review 5.  Cutaneous Lupus Erythematosus: Progress and Challenges.

Authors:  Amy J Petty; Lauren Floyd; Christopher Henderson; Matilda W Nicholas
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-04       Impact factor: 4.806

Review 6.  Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea.

Authors:  Nicole M Fett; David Fiorentino; Victoria P Werth
Journal:  Dermatol Clin       Date:  2016-07       Impact factor: 3.478

7.  Understanding the disease burden and unmet needs among patients with cutaneous lupus erythematosus: A qualitative study.

Authors:  M E Ogunsanya; C M Brown; D Lin; F Imarhia; C Maxey; B F Chong
Journal:  Int J Womens Dermatol       Date:  2018-04-13

Review 8.  Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.

Authors:  Kristen L Chen; Rebecca L Krain; Victoria P Werth
Journal:  F1000Res       Date:  2019-03-25

9.  Interventions for cutaneous disease in systemic lupus erythematosus.

Authors:  Cora W Hannon; Collette McCourt; Hermenio C Lima; Suephy Chen; Cathy Bennett
Journal:  Cochrane Database Syst Rev       Date:  2021-03-09

10.  Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus.

Authors:  Benjamin A Nanes; Jane L Zhu; Benjamin F Chong
Journal:  Lupus Sci Med       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.